Modeling of Cisplatin-Induced Signaling Dynamics in Triple-Negative Breast Cancer Cells Reveals Mediators of Sensitivity

Cell Reports - United States
doi 10.1016/j.celrep.2019.07.070
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

ISL1 Promotes Cancer Progression and Inhibits Cisplatin Sensitivity in Triple-Negative Breast Cancer Cells

International Journal of Molecular Medicine
MedicineGenetics
2018English

Silencing of CXCR4 Sensitizes Triple-Negative Breast Cancer Cells to Cisplatin

Oncotarget
Oncology
2014English

Glutamine Deprivation Plus BPTES Alters Etoposide- And Cisplatin-Induced Apoptosis in Triple Negative Breast Cancer Cells

Oncotarget
Oncology
2016English

Cisplatin Loaded Multiwalled Carbon Nanotubes Induce Resistance in Triple Negative Breast Cancer Cells

Pharmaceutics
Pharmaceutical Science
2018English

Curcumin Restores Sensitivity to Retinoic Acid in Triple Negative Breast Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

FZD7 in Triple Negative Breast Cancer Cells

2011English

Targeted Exosomes‐encapsulated Erastin Induced Ferroptosis in the Triple Negative Breast Cancer Cells

Cancer Science
Cancer ResearchMedicineOncology
2019English

Triple-Negative Breast Cancer

2018English

Glutamine Metabolism Regulates FLIP Expression and Sensitivity to TRAIL in Triple-Negative Breast Cancer Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy